These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 22642932)
21. High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms. Rapado I; Grande S; Albizua E; Ayala R; Hernández JA; Gallardo M; Gilsanz F; Martinez-Lopez J J Mol Diagn; 2009 Mar; 11(2):155-61. PubMed ID: 19225136 [TBL] [Abstract][Full Text] [Related]
22. Apparent 'JAK2-negative' polycythaemia vera due to compound mutations in exon 14. Tiong IS; Casolari DA; Moore S; Nguyen T; Van Velzen MJM; Zantomio D; Scott HS; D'Andrea RJ; Hahn CN; Ross DM Br J Haematol; 2017 Jul; 178(2):333-336. PubMed ID: 27136492 [No Abstract] [Full Text] [Related]
23. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond. Michiels JJ; Berneman Z; Schroyens W; De Raeve H Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092 [TBL] [Abstract][Full Text] [Related]
24. Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations. Bousquet M; Le Guellec S; Quelen C; Rigal-Huguet F; Delsol G; Brousset P Hum Pathol; 2006 Nov; 37(11):1458-64. PubMed ID: 16949922 [TBL] [Abstract][Full Text] [Related]
25. Quantitative bead-based assay for detection of JAK2 exon 12 mutations. Shivarov V; Ivanova M; Yaneva S; Petkova N; Hadjiev E; Naumova E Leuk Lymphoma; 2013 Jun; 54(6):1343-4. PubMed ID: 23121686 [No Abstract] [Full Text] [Related]
26. Nested high-resolution melting curve analysis a highly sensitive, reliable, and simple method for detection of JAK2 exon 12 mutations--clinical relevance in the monitoring of polycythemia. Carillo S; Henry L; Lippert E; Girodon F; Guiraud I; Richard C; Dubois Galopin F; Cleyrat C; Jourdan E; Kralovics R; Hermouet S; Lavabre-Bertrand T J Mol Diagn; 2011 May; 13(3):263-70. PubMed ID: 21497288 [TBL] [Abstract][Full Text] [Related]
27. Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations. Ibrahim IK; Hassan R; Ali EW; Omer A Asian Pac J Cancer Prev; 2019 Jan; 20(1):41-44. PubMed ID: 30677867 [TBL] [Abstract][Full Text] [Related]
28. JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature. Yoo JH; Park TS; Maeng HY; Sun YK; Kim YA; Kie JH; Cho EH; Song J; Lee KA; Suh B; Choi JR Cancer Genet Cytogenet; 2009 Feb; 189(1):43-7. PubMed ID: 19167611 [TBL] [Abstract][Full Text] [Related]
29. Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera. Wu Z; Yuan H; Zhang X; Liu W; Xu J; Zhang W; Guan M PLoS One; 2011; 6(10):e26534. PubMed ID: 22028900 [TBL] [Abstract][Full Text] [Related]
31. A multiplexed fragment analysis-based assay for detection of JAK2 exon 12 mutations. Furtado LV; Weigelin HC; Elenitoba-Johnson KS; Betz BL J Mol Diagn; 2013 Sep; 15(5):592-9. PubMed ID: 23810504 [TBL] [Abstract][Full Text] [Related]
32. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis. Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011 [TBL] [Abstract][Full Text] [Related]
33. Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis. Jones AV; Cross NC; White HE; Green AR; Scott LM Haematologica; 2008 Oct; 93(10):1560-4. PubMed ID: 18698085 [TBL] [Abstract][Full Text] [Related]
34. Methods for detecting mutations in the human JAK2 gene. Bench AJ; Baxter EJ; Green AR Methods Mol Biol; 2013; 967():115-31. PubMed ID: 23296725 [TBL] [Abstract][Full Text] [Related]
35. Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis. Cazzola M Haematologica; 2007 Dec; 92(12):1585-9. PubMed ID: 18055979 [No Abstract] [Full Text] [Related]
36. JAK2-V617F-mutated myeloproliferative neoplasms reveal different allele burden within hematopoietic cell lineages: a microdissection study of bone marrow trephine biopsies. Kreft A; Kindler T; Springer E; Kirkpatrick CJ Virchows Arch; 2011 Nov; 459(5):521-7. PubMed ID: 22006129 [TBL] [Abstract][Full Text] [Related]
37. [Clinical and laboratory features compared between JAK2 exon12 and JAK2 V617F mutated polycythemia vera]. Liu D; Zhang PH; Xu ZF; Ma J; Qin TJ; Qu SQ; Sun XJ; Li B; Pan LJ; Jia YJ; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):107-114. PubMed ID: 35381670 [No Abstract] [Full Text] [Related]
38. In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele. Gaikwad A; Nussenzveig R; Liu E; Gottshalk S; Chang K; Prchal JT Exp Hematol; 2007 Apr; 35(4):587-95. PubMed ID: 17379069 [TBL] [Abstract][Full Text] [Related]
39. JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera. Yoshinaga K; Mori N; Wang YH; Tomita K; Shiseki M; Motoji T Int J Hematol; 2008 Jul; 88(1):82-87. PubMed ID: 18528646 [TBL] [Abstract][Full Text] [Related]
40. Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F. Zaleskas VM; Krause DS; Lazarides K; Patel N; Hu Y; Li S; Van Etten RA PLoS One; 2006 Dec; 1(1):e18. PubMed ID: 17183644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]